A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)

Clinical trial NCT05894083 · RECRUITING

Trial details

NCT number: NCT05894083
Sponsor: University of Michigan Rogel Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Oropharyngeal Cancer Squamous Cell Carcinoma of the Oropharynx

Start date: 2023-04-27
Primary completion: 2026-12-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.